BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23859324)

  • 1. [The prognostic analysis of tumor size in T4a stage gastric cancer].
    Liu HG; Liang H; Deng JY; Wang L; Liang YX; Jiao XG
    Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):230-4. PubMed ID: 23859324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of negative lymph node count in prediction of prognosis of advanced gastric cancer].
    Liu HG; Liang H; Deng JY; Wang L; Liang YX; Jiao XG
    Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):66-70. PubMed ID: 23578432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Oro S; Tatebe S; Tsujitani S; Ikeguchi M
    Am J Surg; 2006 Sep; 192(3):296-300. PubMed ID: 16920421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of tumor size in T3 gastric cancer.
    Liu X; Xu Y; Long Z; Zhu H; Wang Y
    Ann Surg Oncol; 2009 Jul; 16(7):1875-82. PubMed ID: 19373514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in gastric cancer using log-normal censored regression model.
    Pourhoseingholi MA; Moghimi-Dehkordi B; Safaee A; Hajizadeh E; Solhpour A; Zali MR
    Indian J Med Res; 2009 Mar; 129(3):262-7. PubMed ID: 19491418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic significance of tumor size in T3 gastric cancer].
    Chi Z; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Feb; 14(2):114-6. PubMed ID: 21365503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is tumor size a predictor of preoperative N staging in T2-T4a stage advanced gastric cancer?
    Huang CM; Xu M; Wang JB; Zheng CH; Li P; Xie JW; Lin JX; Lu J
    Surg Oncol; 2014 Mar; 23(1):5-10. PubMed ID: 24508061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
    Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of tumor deposits in staging and prognostic evaluation in gastric cancer patients].
    Liang W; Zhou Z; Cui J; Xi H; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):277-282. PubMed ID: 28338160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses.
    Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H
    Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significance of No.13 lymph node dissection in D2 gastrectomy for lower-third advanced gastric cancer].
    Jiao XG; Liang H; Deng JY; Wang L; Liu HG; Liang YX
    Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):235-9. PubMed ID: 23859325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant prognostic factors in patients with early gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate prognostic study on node-positive gastric cancer: is tumor size a prognostic indicator?
    Liu Y; Chen XH; Meng XH; Liu CF; Zhao LL; Han JW; Zhuang LW
    Hepatogastroenterology; 2012; 59(114):623-6. PubMed ID: 22024039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of lymphatic vessel invasion in early gastric cancer: a retrospective study of 188 cases.
    Liu C; Zhang R; Lu Y; Li H; Lu P; Yao F; Jin F; Xu H; Wang S; Chen J
    Surg Oncol; 2010 Mar; 19(1):4-10. PubMed ID: 19042124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.